Exaggerated increase of exercise-induced pulmonary artery pressure in systemic sclerosis patients predominantly results from left ventricular diastolic dysfunction

Clinical Research in Cardiology

Volumn 102, Issue 11, 2013, Pages 813-820

  Ciurzyński, Michał ^a   Bienias, Piotr ^a   Irzyk, Katarzyna ^a   Kostrubiec, Maciej ^a   Bartoszewicz, Zbigniew ^a,b   Siwicka, Maria ^a   Kurzyna, Marcin ^c   Demkow, Urszula ^a   Pruszczyk, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c European Health Centre   (Poland)

Author keywords

Diastolic dysfunction; Echocardiography; Pulmonary hypertension; Scleroderma

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHILD; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPH; ESOPHAGUS VARICES BLEEDING; EXAGGERATED PULMONARY ARTERY PRESSURE RESPONSE TO EXERCISE; EXERCISE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG FUNCTION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; SCHOOL CHILD; SYSTEMIC SCLEROSIS; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID REGURGITATION PEAK GRADIENT; ULTRASOUND TRANSDUCER; WORKLOAD;

ADULT; AGED; ARTERIAL PRESSURE; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; SCLERODERMA, SYSTEMIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84886421415     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0594-x     Document Type: Article

References (30)

1. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-3800
2. Mukerjee D, St GD, Coleiro B, Knight C, Denton CP, Davar J et al (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62(11):1088-1093
3. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB et al (2010) Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138(6):1383-1394
4. Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L et al (2006) Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54(9):3043-3050
5. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory Society (ERS), endorsed by the International Society of heart and lung transplantation (ISHLT). Eur Heart J 30(20):2493-2537
6. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American college of cardiology foundation task force on expert consensus documents and the American heart association developed in collaboration with the American college of chest physicians; American thoracic society, Inc. and the pulmonary hypertension association. J Am Coll Cardiol 53(17):1573-1619
7. Galie N, Rubin L, Hoeper M, Jansa P, Al-Hiti H, Meyer G et al (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371(9630):2093-2100
8. D'Alto M, Ghio S, D'Andrea A, Pazzano AS, Argiento P, Camporotondo R et al (2011) Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis. Heart 97(2):112-117
9. Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C et al (2010) Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography versus right-sided heart catheterization. Chest 138(2):270-278
10. Reichenberger F, Voswinckel R, Schulz R, Mensch O, Ghofrani HA, Olschewski H et al (2009) Non-invasive detection of early pulmonary vascular dysfunction in scleroderma. Respir Med 103(11):1713-1718
11. Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Perez LL, Fernandez RR, Sanchez-Cano D et al (2008) Prevalence of exercise pulmonary arterial hypertension in scleroderma. J Rheumatol 35(9):1812-1816
12. Gargani L, Pignone A, Agoston G, Moreo A, Capati E, Badano LP et al (2013) Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study. Am Heart J 165(2):200-207
13. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R (2008) Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 134(1):146-151
14. Hachulla AL, Launay D, Gaxotte V, de GP, Lamblin N, Devos P et al (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68(12):1878-1884
15. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L et al (2008) Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 58(6):1803-1809
16. - (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581-90
17. Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della RA, Silman AJ et al (2003) European scleroderma study group to define disease activity criteria for systemic sclerosis III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 62(9):901-903
18. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10(2):165-193
19. Feigenbaum H, Armstrong WF, Ryan T (2005) Feigenbaum's echocardiography, 6th edn. Lippincott, Williams and Wilkins, Philadelphia
20. Ciurzynski M, Bienias P, Irzyk K, Rymarczyk Z, Kostrubiec M, Szewczyk A et al (2011) Usefulness of echocardiography in the identification of an excessive increase in pulmonary arterial pressure in patients with systemic sclerosis. Kardiol Pol 69(1):9-15
21. Naeije R, Melot C, Niset G, Delcroix M, Wagner PD (1993) Mechanisms of improved arterial oxygenation after peripheral chemoreceptor stimulation during hypoxic exercise. J Appl Physiol 74(4):1666-1671
22. Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C et al. (2012) Baseline characteristics and follow-up in patients with normal hemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis 71(8):1335-1342
23. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM (2008) Exercise-induced pulmonary arterial hypertension. Circulation 118(21):2183-2189
24. Yagi S, Akaike M, Iwase T, Kusunose K, Niki T, Yamaguchi K et al (2010) Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis. Intern Med 49(21):2309-2312
25. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD et al (2006) Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 130(1):176-181
26. Pignone A, Mori F, Pieri F, Oddo A, Galeota G, Fiori G et al (2007) Exercise doppler echocardiography identifies pre clinic asymptomatic pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 1108:291-304
27. Ha JW, Choi D, Park S, Shim CY, Kim JM, Moon SH et al (2009) Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction. Heart 95(6):490-494
28. Saggar R, Khanna D, Furst DE, Shapiro S, Maranian P, Belperio JA et al (2010) Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 62(12):3741-3750
29. Hager WD, Collins I, Tate JP, Azrin M, Foley R, Lakshminarayanan S et al. (2012) Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients. Clin Respir J [Epub ahead of print]
30. Tschope C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP (2005) The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26(21):2277-2284